KDM4B and prostate carcinoma: In LNCaP cell lines, NSC636819 inhibits the histone demethylation of KDM4A and KDM4B as well as upregulates the H3K9me3 level, ultimately inhibiting the proliferation of prostate cancer cells (Chu et al., 2014).